Intralesional immunotherapy shows promising results in melanoma treatment

Initial clinical trial results demonstrate the efficacy of intralesional immunotherapy in treating malignant melanoma.

Published 11sem1 sourceImportant

≈ 20sSpeed

The fact

This innovative therapeutic approach delivers immunotherapy agents directly into the tumor to optimize immune response.

These positive findings open new perspectives for melanoma patients and may alter oncological protocols.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 6, 2026